No adverse effects on embryo-fetal growth were observed in Expecting rabbits addressed orally with doses up to one hundred mg/kg/working day elafibranor, which generated systemic exposures (combined AUC for elafibranor and GFT1007) through the duration of organogenesis which were less than the human exposure. Administration of 300 mg/kg/day (3. Identify https://tommyj655fyp6.sharebyblog.com/profile